Evidence map›Paper›PMID 32488027›Full record

ArticleScientific reports2020

Ultrafast reprogrammable multifunctional vanadium-dioxide-assisted metasurface for dynamic THz wavefront engineering.

Javad Shabanpour, Sina Beyraghi, Ahmad Cheldavi

Abstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Programmable VOiScience · 2022
    Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Javad ShabanpourDepartment of Electrical Engineering, Iran University of Science and Technology, Narmak, Tehran, 16486-13114, Iran. m.javadshabanpour1372@gmail.com.
Sina BeyraghiDepartment of Electrical Engineering, Iran University of Science and Technology, Narmak, Tehran, 16486-13114, Iran.
Ahmad CheldaviDepartment of Electrical Engineering, Iran University of Science and Technology, Narmak, Tehran, 16486-13114, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this paper, for the first time, a new generation of ultrafast reprogrammable multi-mission bias encoded metasurface is proposed for dynamic terahertz wavefront engineering by employing VO2 reversible and fast monoclinic to tetragonal phase transition. The multi-functionality of our designed VO2 based coding metasurface (VBCM) was guaranteed by elaborately designed meta-atom comprising three-patterned VO2 thin films whose operational statuses can be dynamically tuned among four states of "00"-"11" by merely changing the biasing voltage controlled by an external Field-programmable gate array platform. Capitalizing on such meta-atom design and by driving VBCM with different spiral-like and spiral-parabola-like coding sequences, single vortex beam and focused vortex beam with interchangeable orbital angular momentum modes were satisfactorily generated respectively. Additionally, by adopting superposition theorem and convolution operation, symmetric/asymmetric multiple beams and arbitrarily-oriented multiple vortex beams in pre-demined directions with different topological charges are realized. Several illustrative examples successfully have clarified that the proposed VBCM is a promising candidate for solving crucial terahertz challenges such as high data rate wireless communication where ultrafast switching between several missions is required.

Identifiers

PMID32488027
PMCPMC7265406

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.